Proxima Clinical Research

Proxima CRO is a specialized, full-service contract research organization that serves emerging innovators in drugs, medical devices, diagnostics, and digital therapeutics. It differentiates itself by applying agile project management principles, therapeutic expertise, and technology to streamline clinical development, regulatory strategy, and quality systems. With experience across 35+ therapeutic areas, over 300 clients, and 5,000+ patients enrolled, Proxima positions itself as a strategic partner to accelerate regulatory clearance and improve program outcomes for capital-efficient development.

Service delivery platform applying agile project management principles to clinical and regulatory operations, supported by technology partnerships for data management, eQMS, and analytics.

Proxima competes in the fragmented CRO market, facing competition from large global full-service CROs (e.g., IQVIA, ICON) and many smaller, niche service providers. Its differentiation lies in its focused agile methodology, integrated service model, and specialization in serving innovative device, diagnostic, and biotech companies.